ANALYST-UPGRADE ·Filed Sep 21, 2026

IMNM

Immunome Inc.
BULLISH
Impact 4/10
Processed11d 5h ago SECanalyst-IMNM-alliance-20260921
Alliance Global Partners initiates coverage on IMNM at Buy
Latest settled — T+5d
IMNM ▼ -13.52% at T+5d
LONG call ✗ call lost -13.52% · α vs SPY -13.24% · entry $25.07 → $21.68
Next anchor: T+20d in 17d
Entry anchored
Sep 21, 09:49 AM ET
via 1-min bar
T+1d
+2.71%
call +2.71% · α +2.73%
$25.75
settled 10d ago
T+5d
-13.52%
call -13.52% · α -13.24%
$21.68
settled 4d ago
T+20d
—
call — · α —
—
in 17d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Alliance Global Partners initiates coverage on IMNM at Buy

Impact Score

Base Score
1/7
LLM Adjustment
+0
Final Score
4/10

Consensus & Targets

Buy / Strong Buy
19 (95%)
Hold
1
Sell / Strong Sell
0
Total Analysts
13
Mean PT
$36.31
Median PT
$36.00
High PT
$40.00
Low PT
$30.00
Current Price
$23.97
Implied Upside
+51.5%

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-09-21Alliance Global PartnersinitiateBuy$32.00
2026-09-10HC Wainwright & Co.reiterateBuy$40.00
2026-08-12Truist SecuritiesmaintainBuy$38.00
2026-08-12WedbushmaintainOutperform$35.00
2026-07-21WedbushreiterateOutperform$31.00
2026-06-12WedbushreiterateOutperform$31.00
2026-05-28Truist SecuritiesmaintainBuy$37.00
2026-05-28BarclaysinitiateOverweight$36.00
2026-05-15Leerink PartnersmaintainOutperform$33.00
2026-05-13HC Wainwright & Co.reiterateBuy$40.00

Firm Track Record — Alliance Global Partners

Alliance Global Partners accuracy: 42% on 89 calls | avg return: -5.1%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 7 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
JP Morgan100%2/232.2%top tier
Stephens & Co.67%2/33.3%top tier
Evercore ISI Group50%1/233.3%below average
Lake Street50%1/27.7%below average
Guggenheim50%2/411.8%below average
Piper Sandler33%1/3-6.5%below average
Wedbush25%1/4-19%below average

Earnings Estimates

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
+1y$-2.48$-2.90 — $-2.11$55.6M↑1 ↓0
0y$-2.31$-2.56 — $-2.02$333.3K↑0 ↓0
0q$-0.59$-0.71 — $-0.41$166.7K↑3 ↓0
+1q$-0.61$-0.75 — $-0.38$166.7K↑2 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 5 sells
Institutional
CITADEL ADVISORS LLC — doubled (179.4%)
Institutional
Jump Financial, LLC — trim (-59.7%)
Institutional
Jefferies Financial Group Inc. — exit (-100%)
Short Interest
Short: 327,822 | Exempt: 356 | TRF Vol: 567,934 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

13 reports for IMNM
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +26.53%May 28, 2026
Filters
Rows
Reports for IMNM — sortable, filterable
TypeNow
Oct 1, 2026
1d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$21.58 awaiting T+5awaiting T+5—$20.97 (−2.85%)
Sep 21, 2026
11d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$25.07 $21.68▼ −13.52%▼ −13.24%$20.97 (−16.37%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$26.42 $28.08▲ +6.28%▲ +8.25%$20.97 (−20.65%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.25 $27.56▲ +4.99%▲ +5.39%$20.97 (−20.13%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$23.35 $22.20▼ −4.93%▼ −4.36%$20.97 (−10.21%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.01 $22.59▼ −5.91%▼ −6.78%$20.97 (−12.68%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.01 $22.59▼ −5.91%▼ −6.78%$20.97 (−12.68%)
Jul 3, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$23.61 $24.17▼ −2.37%▼ −1.44%$20.97 (+11.20%)
May 28, 2026
18w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$22.54 $19.81▼ −12.11%▼ −12.06%$20.97 (−6.99%)
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$22.20 $19.66▼ −11.44%▼ −10.28%$20.97 (−5.56%)
Showing 10 of 13

US Market Status

Market Open — Closes in 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 21, 2026